Solid Share Price

Solid Share Price

NASDAQ: SLDB | Small Cap | Healthcare
$6.26
-$0.18 (-2.8%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Solid Stock Performance

Open
$6.22
Prev. Close
$6.44
Circuit Range
N/A
Day Range
$6.20 - $6.53
Year Range
$4.44 - $11.45
Volume
1,49,637
Average Traded
$6.31

Solid Share Price Today

As of 22 November 2026, Solid Biosciences Inc.'s share price is $6.26. The stock opened at $6.22, compared to its previous close of $6.44. During today's trading session, Solid Biosciences Inc.'s share price traded between $6.20 and $6.53, with an average price of $6.36. Over the past 52 weeks, the stock has recorded a high of $11.45 and a low of $4.44. In terms of performance, Solid Biosciences Inc.'s share price has declined by 14.77% over the last six months and is up 15.39% on a year-on-year basis.

Solid Share Price Chart

Line chart of the Solid price trend over the selected period. The price fell overall, ranging from 6.20 to 6.53, ending at 6.26.
$6.20$6.53
L
Show Current Price
H

Solid Stock Fundamentals & Key Indicators

Market Cap
$547.78M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.93
Revenue (TTM)
$0.00
Return On Equity (TTM)
-62.92%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-8.36%

Solid Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$49.79-$56.74-$54.80-$53.95
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-13.96%3.42%1.55%

Solid Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$8.09$0.00$0.00$0.00
Net Profit-$85.98-$96.02-$124.70-$174.33
Net Profit Margin-1062.79%N/AN/AN/A
Income ChangeN/A-11.68%-29.87%-39.80%

Solid Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets27.0831.3635.2140.61
Current Assets205.46157.3129.73219.64
Total Assets232.54188.66164.94260.25
Non Current Liabilities19.0621.1623.9426.08
Current Liabilities33.4730.2614.5222.51
Total Liabilities52.5351.4238.4648.59
Shareholders' Equity180.01137.25126.48211.67

Solid Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-156.29-100.01-94.18-97.98
Investing-58.45-16.099.6959.16
Financing194.45122.443.1274.83

Corporate Actions

Split
Ex-date: 28 Oct 2022

About Solid

Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.

Solid Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$6.23
$6.22
+0.16%
Oct 2026
$7.15
$6.21
-13.99%
Sep 2026
$9.38
$7.22
-28.73%
Aug 2026
$8.05
$10.13
+25.92%
Jul 2026
$10.02
$8.04
-19.39%
Jun 2026
$7.25
$9.98
+35.87%
May 2026
$7.29
$7.34
+1.31%
Apr 2026
$7.31
$7.25
+0.83%
Mar 2026
$6.07
$7.19
+15.59%
Feb 2026
$6.40
$6.22
-3.79%
Jan 2026
$5.58
$6.46
+14.22%
Dec 2025
$5.26
$5.66
+4.33%

Solid Share Price FAQs